IMMY20058 /CAEL101-302/ Frank Passero
Basic Study Information
Purpose:Location: University of Rochester- Wilmot Cancer Center
AL (or light chain) amyloidosis begins in the bone marrow where abnormal proteins
misfold and create free light chains that cannot be broken down. These free light
chains bind together to form amyloid fibrils that build up in the extracellular space
of organs, affecting the kidneys, heart, liver, spleen, nervous system and digestive
The primary purpose of this study is to determine if CAEL-101 improves the overall
survival in Patients with cardiac AL Amyloidosis.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search